Mostrar el registro sencillo del ítem

dc.contributor.authorHaerter, Georg et al.
dc.date.accessioned2020-05-26T21:13:37Z
dc.date.available2020-05-26T21:13:37Z
dc.date.issued2020-05-01
dc.identifier.urihttps://doi.org/10.1101/2020.04.28.20073767en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/1606
dc.description.abstractData on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic is still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Three out of 32 patients with documented outcome died (9%). However, 91% of the patients recovered and 76% have been classified as mild cases, indicating that there is no excess morbidity and mortality among PLWH with symptomatic COVID-19. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen, and 4 on the protease inhibitor darunavir.en_US
dc.languageEnglishen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectInfectious Diseasesen_US
dc.subjectHIVen_US
dc.subjectSARS-CoVen_US
dc.subjectBetacoronavirusen_US
dc.subjectSARS Virusen_US
dc.subjectAnti-Retroviral Agentsen_US
dc.titleCOVID-19 in people living with human immunodeficiency virus: A case series of 33 patientsen_US
eihealth.countryGlobal (WHO/OMS)en_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalmedRxiven_US


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem